Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

Characterizing Novel Olfactory Receptors Expressed in the Renal Cortex.

Halperin Kuhns VL, Sanchez J, Sarver DC, Khalil Z, Rajkumar P, Marr KA, Pluznick JL.

Am J Physiol Renal Physiol. 2019 May 1. doi: 10.1152/ajprenal.00624.2018. [Epub ahead of print]

PMID:
31042061
2.

Empowering ASCI's support of physician-scientists through stronger institutional connections.

Marr KA, Rathmell WK, Hawley JB, Guth KD.

J Clin Invest. 2019 Apr 1;129(4):1516-1518. doi: 10.1172/JCI128898. Epub 2019 Apr 1.

3.

A Multicenter, Longitudinal Cohort Study of Cryptococcosis in HIV-Negative People in the United States.

Marr KA, Sun Y, Spec A, Lu N, Panackal A, Bennett J, Pappas P, Ostrander D, Datta K, Zhang SX, Williamson PR; Cryptococcus Infection Network Cohort (CINCH) Study Working Group.

Clin Infect Dis. 2019 Mar 11. pii: ciz193. doi: 10.1093/cid/ciz193. [Epub ahead of print]

PMID:
30855688
4.

Cryptococcal meningitis is a cause for cross-reactivity in cerebrospinal fluid assays for anti-Histoplasma, anti-Coccidioides and anti-Blastomyces antibodies.

Bahr NC, Panackal AA, Durkin MM, Smedema ML, Keown W, Davis TE, Raymond-Guillen L, Park YD, Marr KA, Fries BC, Williamson PR, Boulware DR, Wheat LJ.

Mycoses. 2019 Mar;62(3):268-273. doi: 10.1111/myc.12882. Epub 2019 Jan 1.

PMID:
30565753
5.

How Clean Is the Linen at My Hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer Centers.

Sundermann AJ, Clancy CJ, Pasculle AW, Liu G, Cumbie RB, Driscoll E, Ayres A, Donahue L, Pergam SA, Abbo L, Andes DR, Chandrasekar P, Galdys AL, Hanson KE, Marr KA, Mayer J, Mehta S, Morris MI, Perfect J, Revankar SG, Smith B, Swaminathan S, Thompson GR, Varghese M, Vazquez J, Whimbey E, Wingard JR, Nguyen MH.

Clin Infect Dis. 2019 Feb 15;68(5):850-853. doi: 10.1093/cid/ciy669.

PMID:
30299481
6.

Urine Antigen Detection as an Aid to Diagnose Invasive Aspergillosis.

Marr KA, Datta K, Mehta S, Ostrander DB, Rock M, Francis J, Feldmesser M.

Clin Infect Dis. 2018 Nov 13;67(11):1705-1711. doi: 10.1093/cid/ciy326.

PMID:
29684106
7.

Immunology of Cryptococcal Infections: Developing a Rational Approach to Patient Therapy.

Elsegeiny W, Marr KA, Williamson PR.

Front Immunol. 2018 Apr 4;9:651. doi: 10.3389/fimmu.2018.00651. eCollection 2018. Review.

8.

Cryptococcus Infection Network in Non-Human Immunodeficiency Virus Cohort (CINCH) Study: Initial Report of Treatment and Outcomes.

Spec A, Panackal A, Williamson P, Bennett JE, Garcia-Diaz J, Ostrander D, Huang CY, Sun Y, Marr KA.

Open Forum Infect Dis. 2016 Oct 24;3(Suppl 1):122. doi: 10.1093/ofid/ofw194.35. eCollection 2016 Fall. No abstract available.

9.

Severe chronic norovirus diarrheal disease in transplant recipients: Clinical features of an under-recognized syndrome.

Avery RK, Lonze BE, Kraus ES, Marr KA, Montgomery RA.

Transpl Infect Dis. 2017 Apr;19(2). doi: 10.1111/tid.12674. Epub 2017 Mar 16.

PMID:
28176463
10.

Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada.

Lavallée C, Labbé AC, Talbot JD, Alonso CD, Marr KA, Cohen S, Laverdière M, Dufresne SF.

Transpl Infect Dis. 2017 Feb;19(1). doi: 10.1111/tid.12648. Epub 2017 Jan 11.

PMID:
27943498
11.

Regulatory Pathways for New Antimicrobial Agents: Trade-offs to Keep the Perfect From Being the Enemy of the Good.

Spellberg B, Marr KA, Brass EP.

Clin Pharmacol Ther. 2016 Dec;100(6):597-599. doi: 10.1002/cpt.510. Epub 2016 Oct 14.

12.

Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection.

Avery RK, Arav-Boger R, Marr KA, Kraus E, Shoham S, Lees L, Trollinger B, Shah P, Ambinder R, Neofytos D, Ostrander D, Forman M, Valsamakis A.

Transplantation. 2016 Oct;100(10):e74-80. doi: 10.1097/TP.0000000000001418.

13.

Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE.

Clin Infect Dis. 2016 Aug 15;63(4):433-42. doi: 10.1093/cid/ciw444.

14.

Dexamethasone in Cryptococcal Meningitis.

Panackal AA, Marr KA, Williamson PR.

N Engl J Med. 2016 Jul 14;375(2):188. doi: 10.1056/NEJMc1605205. No abstract available.

15.

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE.

Clin Infect Dis. 2016 Aug 15;63(4):e1-e60. doi: 10.1093/cid/ciw326. Epub 2016 Jun 29.

16.

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD.

Clin Infect Dis. 2016 Feb 15;62(4):409-17. doi: 10.1093/cid/civ1194. Review.

PMID:
26810419
17.

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.

Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR 3rd, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ.

Lancet. 2016 Feb 20;387(10020):760-9. doi: 10.1016/S0140-6736(15)01159-9. Epub 2015 Dec 10.

PMID:
26684607
18.

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD.

Clin Infect Dis. 2016 Feb 15;62(4):e1-50. doi: 10.1093/cid/civ933. Epub 2015 Dec 16.

19.

False-positive hepatitis C virus serology after placement of a ventricular assistance device.

Durand CM, Marr KA, Ostrander D, Subramanian A, Valsamakis A, Cox A, Neofytos D.

Transpl Infect Dis. 2016 Feb;18(1):146-9. doi: 10.1111/tid.12483. Epub 2016 Jan 30.

PMID:
26565742
20.

Voriconazole therapeutic drug monitoring: results of a prematurely discontinued randomized multicenter trial.

Neofytos D, Ostrander D, Shoham S, Laverdiere M, Hiemenz J, Nguyen H, Clarke W, Brass L, Lu N, Marr KA.

Transpl Infect Dis. 2015 Dec;17(6):831-7. doi: 10.1111/tid.12454. Epub 2015 Nov 25.

21.

Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis.

Neofytos D, Railkar R, Mullane KM, Fredricks DN, Granwehr B, Marr KA, Almyroudis NG, Kontoyiannis DP, Maertens J, Fox R, Douglas C, Iannone R, Kauh E, Shire N.

PLoS One. 2015 Jun 24;10(6):e0129022. doi: 10.1371/journal.pone.0129022. eCollection 2015.

22.

Combination antifungal therapy for invasive aspergillosis: a randomized trial.

Marr KA, Schlamm HT, Herbrecht R, Rottinghaus ST, Bow EJ, Cornely OA, Heinz WJ, Jagannatha S, Koh LP, Kontoyiannis DP, Lee DG, Nucci M, Pappas PG, Slavin MA, Queiroz-Telles F, Selleslag D, Walsh TJ, Wingard JR, Maertens JA.

Ann Intern Med. 2015 Jan 20;162(2):81-9. doi: 10.7326/M13-2508. Erratum in: Ann Intern Med. 2015 Mar 17;162(6):463.

PMID:
25599346
23.

Management of Cryptococcus gattii meningoencephalitis.

Franco-Paredes C, Womack T, Bohlmeyer T, Sellers B, Hays A, Patel K, Lizarazo J, Lockhart SR, Siddiqui W, Marr KA.

Lancet Infect Dis. 2015 Mar;15(3):348-55. doi: 10.1016/S1473-3099(14)70945-4. Epub 2014 Nov 26. Review.

24.

Utility of measuring (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection.

Lyons JL, Thakur KT, Lee R, Watkins T, Pardo CA, Carson KA, Markley B, Finkelman MA, Marr KA, Roos KL, Zhang SX.

J Clin Microbiol. 2015 Jan;53(1):319-22. doi: 10.1128/JCM.02301-14. Epub 2014 Nov 5.

25.

Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr.

Staab JF, Neofytos D, Rhee P, Jiménez-Ortigosa C, Zhang SX, Perlin DS, Marr KA.

Antimicrob Agents Chemother. 2014 Sep;58(9):5421-7. doi: 10.1128/AAC.00096-14. Epub 2014 Jun 30.

26.

Blood dendritic cell levels associated with impaired IL-12 production and T-cell deficiency in patients with kidney disease: implications for post-transplant viral infections.

Chen P, Sun Q, Huang Y, Atta MG, Turban S, Segev DL, Marr KA, Naqvi FF, Alachkar N, Kraus ES, Womer KL.

Transpl Int. 2014 Oct;27(10):1069-76. doi: 10.1111/tri.12381. Epub 2014 Aug 20.

27.

Epidemiology of Candida kefyr in patients with hematologic malignancies.

Dufresne SF, Marr KA, Sydnor E, Staab JF, Karp JE, Lu K, Zhang SX, Lavallée C, Perl TM, Neofytos D.

J Clin Microbiol. 2014 Jun;52(6):1830-7. doi: 10.1128/JCM.00131-14. Epub 2014 Mar 12.

28.

Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).

Kauffman CA, Freifeld AG, Andes DR, Baddley JW, Herwaldt L, Walker RC, Alexander BD, Anaissie EJ, Benedict K, Ito JI, Knapp KM, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Schuster MG, Chiller TM, Pappas PG.

Transpl Infect Dis. 2014 Apr;16(2):213-24. doi: 10.1111/tid.12186. Epub 2014 Mar 4.

29.

Improvement in the outcome of invasive fusariosis in the last decade.

Nucci M, Marr KA, Vehreschild MJ, de Souza CA, Velasco E, Cappellano P, Carlesse F, Queiroz-Telles F, Sheppard DC, Kindo A, Cesaro S, Hamerschlak N, Solza C, Heinz WJ, Schaller M, Atalla A, Arikan-Akdagli S, Bertz H, Galvão Castro C Jr, Herbrecht R, Hoenigl M, Härter G, Hermansen NE, Josting A, Pagano L, Salles MJ, Mossad SB, Ogunc D, Pasqualotto AC, Araujo V, Troke PF, Lortholary O, Cornely OA, Anaissie E.

Clin Microbiol Infect. 2014 Jun;20(6):580-5. doi: 10.1111/1469-0691.12409. Epub 2013 Nov 18.

30.

Detection of cytomegalovirus DNA in plasma as an adjunct diagnostic for gastrointestinal tract disease in kidney and liver transplant recipients.

Durand CM, Marr KA, Arnold CA, Tang L, Durand DJ, Avery RK, Valsamakis A, Neofytos D.

Clin Infect Dis. 2013 Dec;57(11):1550-9. doi: 10.1093/cid/cit521. Epub 2013 Aug 15.

31.

Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.

Mauskopf J, Chirila C, Graham J, Gersten ID, Leather H, Maziarz RT, Baden LR, Bolaños-Meade J, Brown JM, Walsh TJ, Horowitz MH, Kurtzberg J, Marr KA, Wingard JR.

Am J Health Syst Pharm. 2013 Sep 1;70(17):1518-27. doi: 10.2146/ajhp120599.

32.

Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors.

Alonso CD, Dufresne SF, Hanna DB, Labbé AC, Treadway SB, Neofytos D, Bélanger S, Huff CA, Laverdière M, Marr KA.

Biol Blood Marrow Transplant. 2013 Oct;19(10):1502-8. doi: 10.1016/j.bbmt.2013.07.022. Epub 2013 Aug 1.

33.

Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis.

Alonso CD, Marr KA.

Curr Opin Infect Dis. 2013 Aug;26(4):326-31. doi: 10.1097/QCO.0b013e3283630c4c. Review.

34.

Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility.

Datta K, Rhee P, Byrnes E 3rd, Garcia-Effron G, Perlin DS, Staab JF, Marr KA.

J Clin Microbiol. 2013 Sep;51(9):3090-3. doi: 10.1128/JCM.01190-13. Epub 2013 Jun 26.

35.

Galactomannan Antigen Testing for Diagnosis of Invasive Aspergillosis in Pediatric Hematology Patients.

Fisher BT, Zaoutis TE, Park JR, Bleakley M, Englund JA, Kane C, Arceci RJ, Guinan E, Smith FO, Luan X, Marr KA.

J Pediatric Infect Dis Soc. 2012 Jun;1(2):103-11. doi: 10.1093/jpids/pis044. Epub 2012 May 3.

36.

Antiviral immune response after live yellow fever vaccination of a kidney transplant recipient treated with IVIG.

Slifka MK, Hammarlund E, Lewis MW, Poore EA, Hanifin JM, Marr KA, Hecox D, Amanna IJ.

Transplantation. 2013 May 15;95(9):e59-61. doi: 10.1097/TP.0b013e31828c6d9e. No abstract available.

37.

Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.

Neofytos D, Treadway S, Ostrander D, Alonso CD, Dierberg KL, Nussenblatt V, Durand CM, Thompson CB, Marr KA.

Transpl Infect Dis. 2013 Jun;15(3):233-42. doi: 10.1111/tid.12060. Epub 2013 Feb 21.

38.

Cerebrospinal fluid (1,3)-β-D-glucan detection as an aid for diagnosis of iatrogenic fungal meningitis.

Lyons JL, Roos KL, Marr KA, Neumann H, Trivedi JB, Kimbrough DJ, Steiner L, Thakur KT, Harrison DM, Zhang SX.

J Clin Microbiol. 2013 Apr;51(4):1285-7. doi: 10.1128/JCM.00061-13. Epub 2013 Jan 30.

39.

Histoplasmosis and subcutaneous nodules in a kidney transplant recipient: erythema nodosum versus fungal panniculitis.

Dufresne SF, LeBlanc RE, Zhang SX, Marr KA, Neofytos D.

Transpl Infect Dis. 2013 Apr;15(2):E58-63. doi: 10.1111/tid.12052. Epub 2013 Jan 20.

40.

Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.

Flowers CR, Seidenfeld J, Bow EJ, Karten C, Gleason C, Hawley DK, Kuderer NM, Langston AA, Marr KA, Rolston KV, Ramsey SD.

J Clin Oncol. 2013 Feb 20;31(6):794-810. doi: 10.1200/JCO.2012.45.8661. Epub 2013 Jan 14.

PMID:
23319691
41.

Delayed opportunistic infections in hematopoietic stem cell transplantation patients: a surmountable challenge.

Marr KA.

Hematology Am Soc Hematol Educ Program. 2012;2012:265-70. doi: 10.1182/asheducation-2012.1.265. Review.

42.

Treatment of iatrogenic fungal infections: a black mold defines a new gray zone in medicine.

Shoham S, Marr KA.

Ann Intern Med. 2013 Feb 5;158(3):208-10. doi: 10.7326/0003-4819-158-3-201302050-00572. No abstract available.

43.

Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy.

Neofytos D, Lu K, Hatfield-Seung A, Blackford A, Marr KA, Treadway S, Ostrander D, Nussenblatt V, Karp J.

Diagn Microbiol Infect Dis. 2013 Feb;75(2):144-9. doi: 10.1016/j.diagmicrobio.2012.10.001. Epub 2012 Nov 8.

44.

Prevention and treatment of cancer-related infections.

Baden LR, Bensinger W, Angarone M, Casper C, Dubberke ER, Freifeld AG, Garzon R, Greene JN, Greer JP, Ito JI, Karp JE, Kaul DR, King E, Mackler E, Marr KA, Montoya JG, Morris-Engemann A, Pappas PG, Rolston K, Segal B, Seo SK, Swaminathan S, Naganuma M, Shead DA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 Nov 1;10(11):1412-45.

PMID:
23138169
45.

Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosis.

Dufresne SF, Datta K, Li X, Dadachova E, Staab JF, Patterson TF, Feldmesser M, Marr KA.

PLoS One. 2012;7(8):e42736. doi: 10.1371/journal.pone.0042736. Epub 2012 Aug 10.

46.

Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.

Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan SP, Meier-Kriesche HU, Apewokin S, Horn DL.

J Infect. 2012 Nov;65(5):453-64. doi: 10.1016/j.jinf.2012.08.003. Epub 2012 Aug 13.

PMID:
22898389
47.

Cryptococcus gattii as an important fungal pathogen of western North America.

Marr KA.

Expert Rev Anti Infect Ther. 2012 Jun;10(6):637-43. doi: 10.1586/eri.12.48.

48.

Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.

Baddley JW, Andes DR, Marr KA, Kauffman CA, Kontoyiannis DP, Ito JI, Schuster MG, Brizendine KD, Patterson TF, Lyon GM, Boeckh M, Oster RA, Chiller T, Pappas PG.

Med Mycol. 2013 Feb;51(2):128-35. doi: 10.3109/13693786.2012.690108. Epub 2012 Jun 11.

PMID:
22680976
49.

Diagnostic and therapeutic challenges in a liver transplant recipient with central nervous system invasive aspergillosis.

Neofytos D, Shoham S, Dierberg K, Le K, Dufresne S, Zhang SX, Marr KA.

Diagn Microbiol Infect Dis. 2012 Aug;73(4):374-5. doi: 10.1016/j.diagmicrobio.2012.05.001. Epub 2012 Jun 5.

50.

Invasive fungal infections in solid organ transplant recipients.

Shoham S, Marr KA.

Future Microbiol. 2012 May;7(5):639-55. doi: 10.2217/fmb.12.28. Review.

Supplemental Content

Support Center